Metabolism

Hyperpolarized MRI Tracks Liver Enzyme Activity in Fatty Liver

Researchers used a carbon-13 molecular probe to visualize declining paraoxonase activity in animal models of steatohepatitis.

Published November 19, 2026 Read 3 min 417 words Topic Metabolism
Reviewed by: Dr. Michael Teplitsky, MD · November 2026

Mapping Liver Enzyme Activity with Hyperpolarized MRI

A research team in Japan has developed a magnetic resonance imaging (MRI) method that tracks the activity of an essential liver enzyme in living tissue. Paraoxonase (PON) is an enzyme produced primarily in the liver that assists with lipid metabolism and helps protect cells against oxidative stress.

Investigators led by Yoichi Takakusagi at the National Institutes for Quantum Science and Technology (QST), alongside collaborators from Nippon Sanso Corporation, published the findings in the journal Sensors & Diagnostics. Their approach uses a specialized molecular probe to measure enzyme performance noninvasively.

How the Molecular Probe Amplifies the MRI Signal

The experimental imaging technique relies on a carbon-13 molecular probe that temporarily magnifies metabolic signals inside the body. The research team synthesized carbon-13-labeled mevalonolactone ([1-¹³C]MVL) to act as a target for the PON enzyme.

When the probe enters the liver, active PON converts mevalonolactone (MVL) into mevalonic acid (MVA). By comparing the signals from both molecules, researchers can calculate local enzyme activity.

Standard MRI equipment cannot easily detect these subtle biochemical reactions. To solve that problem, the team used a SpinAligner hyperpolarizer at QST to boost the probe signal by approximately 230,000 times. That amplified signal persisted long enough for a 20-second scan to capture the enzymatic reaction in mice.

Tracking Metabolic Dysfunction Progression in Preclinical Models

In mouse models fed an induction diet, liver enzyme activity dropped progressively as metabolic disease grew more severe. The investigators tested the method across stages of metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH).

MASLD is a common metabolic condition estimated to affect roughly one in three adults. The condition frequently develops without obvious early symptoms, but it can advance to fibrosis, cirrhosis, and liver cancer.

Conventional blood tests often fail to reflect actual enzyme activity inside liver tissue because local cellular conditions alter enzyme function. The hyperpolarized imaging probe detected clear declines in living tissue function that standard systemic panels might miss.

Current Evidence Boundaries and Clinical Context

This diagnostic imaging approach remains in the preclinical research phase and has undergone testing only in laboratory mice. Clinical translation requires confirming whether the probe behaves safely in humans and whether the 20-second scan window remains practical in larger bodies.

Standard medical care for fatty liver disease still relies on routine blood tests, abdominal ultrasound, transient elastography, and liver biopsies. Individuals evaluating their metabolic risk should speak with a physician about established diagnostic pathways rather than experimental imaging protocols.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.
Primary source: View original source — referenced for fact-checking; this analysis is independent editorial content.
Found this useful?

Related Articles

Want a clinician to work up your metabolic numbers?

Opt Health runs fasting insulin, A1C, a full lipid panel and 50+ other markers, then builds a treatment plan — GLP-1s included where they're appropriate — with a physician who reviews the data with you directly.

See Opt Health's metabolic program →

Topic updates

Get the weekly metabolic health roundup

Insulin resistance, blood sugar, visceral fat, GLP-1 plateaus, metabolic syndrome, and weight-loss physiology.

No spam. Unsubscribe anytime.

Understand Your Health Better

Our free assessment maps your symptoms to the most relevant guides, tools, and product recommendations.

Take the Free Assessment →

Free · Takes 5 minutes · Instant results